Compare GeneDx Holdings Corp (WGS) vs Wheaton Precious Metals Corp (WPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GeneDx Holdings Corp vs Wheaton Precious Metals Corp — how do they compare? GeneDx Holdings Corp trades at $67.33 (market cap $2.02B), while Wheaton Precious Metals Corp trades at $138.65 (market cap $61.17B). The key difference: Wheaton Precious Metals Corp is far larger — about 30.3× GeneDx Holdings Corp's market cap, and Wheaton Precious Metals Corp pays a 0.58% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold GeneDx Holdings Corp for 19 Days and Wheaton Precious Metals Corp for 66 Days on average.
| WGS | WPM | |
|---|---|---|
Market Cap | $2.02B | $61.17B |
Volume | 734,640 | 1,092,361 |
Sector | Health | Basic Materials |
52-Week High | $167.51 | $165.72 |
52-Week Low | $34.51 | $94.37 |
Typical Hold Time | 19 Days | 66 Days |
Enterprise Value | $2.05B | $63.05B |
Dividend Yield | — | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GeneDx (WGS) trades at $67.33, down 1.75% today, with a mixed technical picture showing bearish moving averages but oversold RSI readings. The company reported Q2 2026 revenue of $114.4M, beating expectations with a return to adjusted profitability, though full-year 2026 shows negative net margins. Recent news highlights product launches and positive analyst coverage with 91% buy ratings.
While analyst consensus is strongly bullish with an $81 price target, fundamental risks remain due to negative profitability and high valuation multiples. The stock offers potential upside if operational improvements continue, but investors face execution risk amid ongoing losses and competitive pressures in the genomics space.
Wheaton Precious Metals (WPM) trades at $134.96, up 0.95% on the day, with a bearish technical signal but strong fundamentals. The company reported record H1 2026 revenues and has beaten earnings estimates for three consecutive quarters. Management targets 50% production growth by 2030 without new capital, supported by a robust pipeline of streaming deals. Cash flow from operations surged to $1.9 billion in 2025, though 2026 projections show significant investing outflows.
The outlook is supported by analyst consensus with an 80% buy rating and a $164.80 price target, implying 22% upside. Key risks include execution of growth targets, gold price volatility, and high valuation multiples. The stock offers exposure to precious metals with a capital-light model, but investors face near-term technical headwinds amid broader market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →About Wheaton Precious Metals Corp
Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →
